Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guben Huayu Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by the Guangdong Provincial Hospital of Chinese Medicine for the treatment of moderate-to-severe psoriasis. It is specifically indicated for patients exhibiting the 'blood-stasis' pattern, a TCM classification characterized by chronic, dark-colored plaques. The formula is designed to 'strengthen the foundation' (Guben) and 'resolve blood stasis' (Huayu). In clinical research, it has been evaluated in combination with methotrexate to improve clinical outcomes, such as the Psoriasis Area and Severity Index (PASI) score, and to modulate inflammatory pathways and the skin microbiome.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on guben huayu decoction.